| uniQure Announces Dosing of First Patient in Phase I/IIa Clinical Trial of AMT-191 for the Treatment of Fabry Disease | 08/15 07:05 | globenewswire.com |
| uniQure: Pullback After Strong Interim Treatment Data Creates Buying Opportunity | 08/06 03:03 | seekingalpha.com |
| UniQure (QURE) Reports Q2 Loss, Tops Revenue Estimates | 08/01 09:25 | zacks.com |
| uniQure Announces Second Quarter 2024 Financial Results and Provides Company Update | 08/01 07:05 | globenewswire.com |
| Wall Street Analysts See a 125.9% Upside in uniQure (QURE): Can the Stock Really Move This High? | 07/26 10:55 | zacks.com |
| uniQure Announces Closing of Sale of Manufacturing Facility to Genezen | 07/23 07:05 | globenewswire.com |
| What Led To A 150% Rise In UniQure Stock In A Week? | 07/12 08:00 | forbes.com |
| Wall Street Analysts Think uniQure (QURE) Could Surge 195.8%: Read This Before Placing a Bet | 07/10 10:55 | zacks.com |
| uniQure (QURE) Soars on New Huntington's Disease Study Data | 07/10 10:06 | zacks.com |
| uniQure (QURE) Surges 76.5%: Is This an Indication of Further Gains? | 07/10 06:50 | zacks.com |